Philips Introduces SmartCT for Advanced Stroke Imaging Care
Philips Launches SmartCT for Enhanced Stroke Care
In a groundbreaking development, Royal Philips, a prominent leader in health technology, has unveiled its advanced SmartCT solution for intelligent 3D imaging, aimed at transforming stroke care in Europe. This innovative imaging system enables healthcare professionals to act swiftly and confidently during critical neurovascular procedures, marking a significant enhancement in patient care.
Product Features and Benefits
Showcased at a major medical event in Europe, Philips' SmartCT is designed to streamline the imaging process in the Angio suite. This state-of-the-art technology offers rapid and intelligent 3D imaging capabilities that empower physicians to make quicker decisions, ultimately improving patient outcomes. Earlier available in regions like Japan and Canada, SmartCT has now received CE marking, paving its way for widespread usability across European healthcare facilities.
Real-Time Imaging for Life-Saving Interventions
SmartCT operates seamlessly alongside the Philips Azurion neuro biplane system, greatly enhancing the 3D imaging process. With capabilities to provide real-time visualization of brain tissue and crucial blood vessels, this technology eliminates the need for time-consuming patient transfers to separate CT facilities. The result is a significant increase in operational efficiency, allowing healthcare teams to enhance time-critical treatments such as mechanical thrombectomy, a key intervention for ischemic stroke management.
Expert Insights on SmartCT Technology
Dr. Atul Gupta, Chief Medical Officer for Diagnosis and Treatment at Philips, emphasizes the urgency of speed and trust in stroke care, stating, "Every minute counts, and confidence is paramount. With SmartCT, we're equipping neuro interventionalists with the right tools precisely when they need them, minimizing delays and boosting their ability to save lives." This sentiment is echoed by leading clinicians utilizing SmartCT, which has drastically improved workflow and reduced procedural complexities in stroke centers worldwide.
Innovative Features of SmartCT 3.0
The SmartCT 3.0 brings a suite of advanced functionalities that further optimize stroke management:
- SmartCT Soft Tissue Helical: This feature enables cone-beam CT imaging in as little as eight seconds. It enhances the visualization of brain soft tissue, greatly aiding in the assessment of cerebral health.
- Motion-Compensated Imaging: Specifically designed for restless patients, this technology ensures high-quality imaging, crucial during emergency procedures.
- SmartCT Dual Phase Cerebral: This function provides exceptional imaging of vessel occlusions alongside collateral blood flow, essential for effective treatment planning.
- SmartCT Dual Viewer: This innovative aspect allows physicians to analyze two 3D volumes simultaneously, facilitating real-time image fusion to support effective and sterile procedural planning.
Upcoming Demonstrations at LINNC Paris 2025
Philips will present the latest advancements in SmartCT technology at LINNC Paris 2025. This premier interventional neuroradiology congress is an excellent venue for healthcare professionals to explore hands-on demonstrations and learn more about the Azurion biplane system with SmartCT 3.0. Attendees are welcome to visit Booth #28 to experience firsthand the transformative impact of this technology on neuro-endovascular interventions.
About Royal Philips
Royal Philips (NYSE: PHG) stands at the forefront of health technology innovation, dedicated to enhancing people's health and well-being through cutting-edge solutions. With a strong emphasis on both consumer-centric and professional health solutions, Philips leverages deep clinical insights and advanced technology to meet diverse healthcare demands. The company, headquartered in the Netherlands, has demonstrated remarkable growth, achieving substantial sales and expanding its global presence, serving over 100 countries. More updates on Philips' initiatives and advancements can be found on their official website.
Frequently Asked Questions
What is SmartCT?
SmartCT is an advanced imaging solution developed by Royal Philips that provides intelligent 3D imaging to enhance neurovascular procedures, particularly in stroke care.
How does SmartCT improve stroke treatment?
This technology allows for rapid imaging directly in the Angio suite, reducing patient transfer time and enabling quicker decision-making, which is crucial in stroke management.
Where can I see SmartCT in action?
Philips will demonstrate SmartCT at LINNC Paris 2025, providing healthcare professionals an opportunity to experience its features and benefits firsthand.
What are the key features of SmartCT 3.0?
Key features include SmartCT Soft Tissue Helical, motion-compensated imaging, SmartCT Dual Phase Cerebral, and SmartCT Dual Viewer, all designed to optimize imaging and procedural efficiency.
How does Philips contribute to healthcare globally?
Philips focuses on meaningful innovation in health technology, providing solutions that enhance the quality of care for patients and healthcare providers alike around the world.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.